Uea Enterprises Ltd investment portfolio

CELLEXCEL LTD develops patented technology for chemically modifying biomaterials to enhance properties like water resistance, enabling their use in demanding applications. The company targets OEMs and product manufacturers in industries such as automotive, aerospace, construction, and electronics, helping them integrate sustainable biocomposites to reduce carbon emissions.

IsoChemiX designs and manufactures stable‑isotope‑labelled compounds and provides metabolomics platforms for pharmaceutical and clinical discovery research, serving pharma companies and academic research groups.